Multiple Myeloma
News
Multiple Myeloma Treatment Does Not Affect the Outcome of Stem Cell Transplant
(04/18/2008)
A recently published study indicates that the type of initial chemotherapy for multiple myeloma has no impact on the outcome of patients who later undergo autologous stem cell transplant. These findings appeared in an early online publication of Bone Marrow Transplantation.
Being Overweight Associated with Increased Risk of Several Cancers
(02/19/2008)
Excess bodyweight increases the risk of developing several types of cancer, according to results recently published in The Lancet.
Additional Evidence Shows Thalomid® Improves Survival in Elderly with Multiple Myeloma
(01/16/2008)
According to results recently presented at the 2007 annual meeting of the American Society of Hematology, additional evidence confirms that the addition of Thalomid® (thalidomide) to Alkeran® (melphalan) and prednisone improves survival in elderly patients with multiple myeloma.
Low-dose Steroids Improve Survival in Multiple Myeloma
(12/14/2007)
According to results recently presented at the 2007 annual meeting of the American Society of Hematology, use of low doses of the steroid dexamethasone in combination with Revlimid® (lenalidomide) provided significantly improved survival in multiple myeloma compared with higher-doses of the steroid in this treatment combination.
Revlimid® Improves Survival in Relapsed Multiple Myeloma
(11/26/2007)
According to two articles recently published in the New England Journal of Medicine, Revlimid® (lenalidomide) improves survival for patients with multiple myeloma that has returned following prior therapies.
More
Multiple Myeloma
Cancer News...